Trulieve Cannabis Corp.
TRLV· NYSE
Filed Aug 6, 2025 · 10-Q · 37 days after period end · 0001754195-25-000053
| Metric | Q2 2025 | Q2 2024 | Q2 2023 | Q2 2022 |
|---|---|---|---|---|
| Revenue | $302.09M | $303.44M | $281.80M | $313.84M |
| Net Income | -$16.11M | -$11.98M | -$406.87M | -$24.02M |
| EPS Diluted | -$0.07 | -$0.04 | -$1.80 | -$0.09 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Trulieve Cannabis Corp. · CIK 1754195 · Engraved from SEC EDGAR
ended Jun 30, 2025 · filed Aug 6, 2025 · 37 d after period end